Skip to main content

Table 3 Associations between general and respiratory complications and population characteristics

From: Ten-year experience with standardized non-operating room anesthesia with Sevoflurane for MRI in children affected by neuropsychiatric disorders

 

General complications development

Respiratory complications development

Yes (86)

No (1303)

Pa

Yes (43)

No (1346)

Pa

ASA score > 1

(No. (%))

20

(23.3)

158

(12.1)

0.003

12

(27.9)

166

(12.3)

0.003

Age

Median [IQR], months

54

[36–96]

48

[27–84]

0.050

60

[36–96]

48

[27–84]

0.071

Weight

Median [IQR]), kg

18.6

[12.5–27.0]

16.6

[12.0–24.0]

0.170

18.9

[12.0–24.0]

17.0

[12.0–24.2]

0.356

Male sex

No. (%)

62

(72.1)

784

(60.2)

0.028

32

(74.4)

814

(60.5)

0.065

Neuromuscolar diseases

No. (%)

5

(5.8)

52

(4.0)

0.409

5

(11.6)

52

(3.9)

0.028

Premedication

No. (%)

1063

(81.6)

71

(82.6)

0.821

34

(79.1)

1100

(81.7)

0.658

Multipharmacological anaesthesia

No. (%)

7

(8.1)

39

(3.0)

0.010

0

(0.0)

46

(3.4)

0.218

Anaesthesia length > 50 min

No. (%)

67

(77.9)

875

(67.2)

0.039

35

(81.4)

907

(67.4)

0.053

Season autumn-winter

No. (%)

47

(54.7)

633

(48.6)

0.276

28

(65.1)

652

(48.4)

0.031

  1. aP value for Pearson Chi-squared test and Wilcoxon rank-sum test
  2. ASA American society of anesthesiologists; IQR Inter-quartile range
  3. The level of statistical significance at 0.05 is set in bold